A potential strategy to control MAPK4-dependent cancer growth
This study has advanced our understanding of the molecular mechanisms underlying the tumor-promoting activity of MAPK4.
Read MoreThis study has advanced our understanding of the molecular mechanisms underlying the tumor-promoting activity of MAPK4.
Read MoreThe findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.
Read MoreThe researchers took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy.
Read MoreThe bone microenvironment prompts changes in breast cancer cells that help them escape treatment and become more invasive.
Read MoreInhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.
Read MoreDetailed 3-D studies reveal how the androgen receptor is put together as a functional complex that drives prostate cancer.
Read MoreA fusion gene is a new gene made by joining parts of two different genes. The current thought is that fusion genes can happen in
Read MoreThe five winners of this year’s Michael E. DeBakey M.D. Award for Research Excellence exemplify the breadth and depth of scientific research at Baylor College
Read MoreGenetic factors can explain, at last in part, the higher incidence of prostate cancer among African American men compared with men of other ethnic groups.
Read MoreDuring the month of September, Baylor College of Medicine will be partnering with the Blue Cure Foundation for its annual prostate cancer awareness campaign, Light
Read More